Browsing by Yonsei Author

Name:
김주항 [Kim, Joo Hang]
Department :
College of Medicine : Dept. of Internal Medicine
Issue DateTitleAuthor(s)
2016 Definitive Chemoradiotherapy Versus Surgery Followed by Adjuvant Radiotherapy in Resectable Stage III/IV Hypopharyngeal Cancer 금기창, 김세헌, 김주항, 김준원, 이창걸
2016 Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapy 김주항, 김혜련, 박형순, 이민구, 조병철, 조응혁
2016 Survivin silencing and TRAIL expression using oncolytic adenovirus increase anti-tumorigenic activity in gemcitabine-resistant pancreatic cancer cells 김주항, 송재진, 최혜진
2016 Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer. 김영진, 김주항, 문용화, 서영주, 심효섭, 이혜정, 임동진, 조응혁, 최병욱, 허진, 홍유진
2015 Phase II clinical and exploratory biomarker study of dacomitinib in patients with recurrent and/or metastatic squamous cell carcinoma of head and neck 조병철, 최은창, 고윤우, 권형주, 김주항, 김한상, 김혜련, 백순명, 이민구, 이지현, 정인경
2015 Ratio of phosphorylated HSP27 to nonphosphorylated HSP27 biphasically acts as a determinant of cellular fate in gemcitabine-resistant pancreatic cancer cells 김주항, 송재진, 최혜진
2015 Silencing Daxx increases the anti-tumor activity of a TRAIL/shRNA Bcl-xL-expressing oncolytic adenovirus through enhanced viral replication and cellular arrest 김주항, 송재진
2015 Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinoma. 김혜련, 김효송, 박준철, 신성관, 이상길, 이용찬, 이창걸, 정다현, 정현수, 조병철, 허진, 김대준, 김주항, 김현기
2015 Anaplastic lymphoma kinase gene copy number gain in inflammatory breast cancer (IBC): prevalence, clinicopathologic features and prognostic implication 김승일, 박형석, 손주혁, 김주항, 박병우, 박세호, 구자승, 정준
2015 The frequency and impact of FGFR1 amplification on clinical outcomes in Korean patients with small cell lung cancer 심효섭, 이창영, 장준, 정인경, 정지예, 조병철, 김대준, 김세규, 김은영, 김주항, 김혜련, 김효송
2015 An open label, multicenter, phase II study of dovitinib in advanced thyroid cancer 강상욱, 강찬우, 김주항, 김혜련, 남기현, 임선민, 임재윤, 정웅윤, 조병철
2015 LAMC2 enhances the metastatic potential of lung adenocarcinoma 정현철, 김주항, 문용화, 심효섭
2014 Prediction for response duration to epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR mutated never smoker lung adenocarcinoma 조병철, 김대준, 김세규, 김주항, 김혜련, 심효섭, 임선민, 장준
2014 A prospective phase II trial of s-1 and cisplatin-based chemoradiotherapy for locoregionally advanced esophageal cancer 이혁, 정현수, 조병철, 김대준, 차지혜, 김주항, 허진, 김충배, 김형일, 김혜련, 박준철, 배미경, 신성관, 이상길, 이용찬, 이진구, 이창걸, 이창영
2014 Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinoma 김주항, 김현정, 김혜련, 배미경, 심효섭, 이진구, 이창영, 임선민, 정경영, 정지예, 조병철, 김대준, 김민환, 김은영
2014 Impact of cigarette smoking on response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutations 김혜련, 배미경, 이재석, 이창영, 조병철, 강대용, 김민환, 김은영, 김주항
2014 Identification of somatic mutations in EGFR/KRAS/ALK-negative lung adenocarcinoma in never-smokers 장준, 정경영, 김대준, 정지예, 김세규, 조병철, 김은영, 김주항, 김한상, 김혜련, 배미경, 심효섭, 이민구, 이지현, 이진구, 이창영
2014 Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial. 김주항
2014 Clinical Outcome According to the Level of Preexisting Epidermal Growth Factor Receptor T790M Mutation in Patients With Lung Cancer Harboring Sensitive Epidermal Growth Factor Receptor Mutations 김주항
2014 Tumor MET expression profile predicts the outcome of non-small cell lung cancer patients receiving epidermal growth factor receptor tyrosine kinase inhibitors 김주항, 박희진, 조병철
2014 Establishment of a mouse melanoma model system for the efficient infection and replication of human adenovirus type 5-based oncolytic virus 송재진, 김주항
2013 TRAIL/MEKK4/p38/HSP27/Akt survival network is biphasically modulated by the Src/CIN85/c-Cbl complex 김주항, 송재진
2013 A phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC) 김선미, 홍윤경, 김세현, 김주항, 김혜련, 심효섭, 장현, 조병철, 조재호
2013 Transforming growth factor-β gene silencing using adenovirus expressing TGF-β1 or TGF-β2 shRNA 김주항, 송재진
2013 c-Cbl shRNA-expressing adenovirus sensitizes TRAIL-induced apoptosis in prostate cancer DU-145 through increases of DR4/5 김주항, 송재진
2013 The effectiveness of the oncolytic activity induced by Ad5/F35 adenoviral vector is dependent on the cumulative cellular conditions of survival and autophagy 김주항, 송재진
2013 Fibroblast Growth Factor Receptor 1 Gene Amplification Is Associated With Poor Survival and Cigarette Smoking Dosage in Patients With Resected Squamous Cell Lung Cancer 심효섭, 이지현, 강대용, 이진구, 김대준, 이창영, 김세훈, 임선민, 김주항, 정경영, 김혜련, 조병철, 라선영, 배미경
2013 Crosstalk from survival to necrotic death coexists in DU-145 cells by curcumin treatment: Inhibition of apoptosis by caspase degradation. 김주항, 송재진
2013 The Impact of Cigarette Smoking on the Frequency of and Qualitative Differences in KRAS Mutations in Korean Patients with Lung Adenocarcinoma 조병철, 홍윤경, 김주항, 김혜련, 남기창, 라선영, 안정련, 이진구
2013 Phase II study of camtobell inj. (belotecan) in combination with cisplatin in patients with previously untreated, extensive stage small cell lung cancer 김은영, 김주항, 김한상, 김혜련, 박무석, 박지수, 이준호, 임선민, 임승택, 장준, 정지예, 김건민, 조병철, 김다래, 김세규, 김세현, 김영삼
2013 The frequency and impact of ROS1 rearrangement on clinical outcomes in never smokers with lung adenocarcinoma 김주항, 김혜련, 배미경, 심효섭, 조병철
2013 Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumors 김주항, 김한상, 김효송, 노재경, 라선영, 손주혁, 신상준, 안중배, 이수현, 정현철, 조병철, 최혜진
2013 Pharmacogenomic Assessment of Outcomes of Pemetrexed-Treated Patients with Adenocarcinoma of the Lung 강영애, 김대준, 김세규, 김주항, 라선영, 박형순, 이지현, 이철호, 장준, 정민규, 조병철
2013 Prognostic value of 19F-fluorodeoxyglucose positron emission tomography in patients with resectable pancreatic cancer 송시영, 윤미진, 이우정, 이재훈, 이종두, 조응혁, 최혜진, 강창무, 김주항
2013 Better Outcome of XELOX Chemotherapy in Patients with Advanced Intestinal-Type Adenocarcinoma of the Ampulla of Vater 김주항, 김한상, 김현기, 신상준, 최혜진
2013 Glycolysis Inhibition Sensitizes Non–Small Cell Lung Cancer with T790M Mutation to Irreversible EGFR Inhibitors via Translational Suppression of Mcl-1 by AMPK Activation 김선미, 김주항, 조병철
2013 S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial 구자승, 김민정, 김승일, 김은경, 김주항, 박병우, 박세호, 손주혁, 이수현, 정현철
2013 Prolonged clinical benefit from the maintenance hormone therapy in patients with metastatic breast cancer 김주항, 박병우, 박세호, 손주혁, 이수현, 임승택, 최혜진, 한정우, 김승일
2013 A multicenter, phase II trial of everolimus in locally advanced or metastatic thyroid cancer of all histologic subtypes 강상욱, 김주항, 김현정, 남기현, 박정수, 윤미진, 임선민, 정웅윤, 조병철
2012 Phase II study of cisplatin with irinotecan as induction chemotherapy followed by chemoradiotherapy for unresectable stage III non-small cell lung cancer 김혜련, 윤상현, 이창걸, 장현, 조병철, 김세현, 김주항
2012 Additional diagnostic value of tumor markers in cytological fluid for diagnosis of non-small-cell lung cancer 장준, 정경영, 최병욱, 허진, 홍유진, 김세규, 김영진, 김주항, 김희영, 남지은, 이혜선, 이혜정
2012 Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement. 김세규, 김세훈, 김주항, 김혜련, 라선영, 심효섭, 정경영, 조병철, 홍윤경
2012 The efficacy and toxicity of S-1 and cisplatin as first-line chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma. 김세헌, 김효송, 조병철, 최은창, 고윤우, 김주항, 김건민, 김한상, 김선미, 김혜련
2012 HSP27 modulates survival signaling networks in cells treated with curcumin and TRAIL. 김주항, 송재진
2012 High EGFR gene copy number and skin rash as predictive markers for EGFR tyrosine kinase inhibitors in patients with advanced squamous cell lung carcinoma. 김세훈, 김주항, 박무석, 심효섭, 조병철
2012 Efficacy and toxicity of belotecan for relapsed or refractory small cell lung cancer patients 조병철, 강영애, 김건민, 김선미, 김세규, 김영삼, 김주항, 임승택
2012 Activation of IL-6R/JAK1/STAT3 signaling induces de novo resistance to irreversible EGFR inhibitors in non-small cell lung cancer with T790M resistance mutation 홍윤경, 권오준, 김선미, 김주항, 이지현, 조병철
2012 Overexpression of class III beta tubulin and amplified HER2 gene predict good response to paclitaxel and trastuzumab therapy 김주항, 정현철, 라선영, 홍수정, 문용화, 박병우, 박세호, 손주혁, 구자승, 이수현, 김승일, 정민규
2012 Treatment outcome of patients with anaplastic thyroid cancer: a single center experience 박정수, 신상준, 임선민, 정웅윤, 조병철, 조재용, 강상욱, 금기창, 김주항, 남기현
2012 EGFR polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI 정민규, 조병철, 강영애, 김대준, 김세규, 김주항, 라선영, 박형순, 이지현, 이철호, 장준
2011 TRAIL-induced caspase/p38 activation is responsible for the increased catalytic and invasive activities of Akt 김소영, 김주항, 선보경, 송재진, 오세은, 응구엔응옥호안
2011 K1/MEKK4 are responsible for TRAIL-induced JNK/p38 phosphorylation 김소영, 김주항, 선보경, 송재진, 오세은, 응구엔응옥호안, 최혜진
2011 Lung cancer in never smokers: change of a mindset in the molecular era. 김세규, 김주항, 조병철
2011 A phase I study of nimotuzumab in combination with radiotherapy in stages IIB-IV non-small cell lung cancer unsuitable for radical therapy: Korean results. 김세규, 김주항, 박무석, 손주혁, 심효섭, 양우익, 이익재, 이주희, 이창걸, 최혜진, 권지은
2011 Analysis of tumor markers in the cytological fluid obtained from computed tomography-guided needle aspiration biopsy for the diagnosis of non-small cell lung cancer 김영진, 김주항, 김화선, 김희영, 남지은, 이혜정, 장준, 정경영, 최규옥, 최병욱, 허진, 홍유진, 김세규
2011 Prognostic and predictive value of CEA and CYFRA 21-1 levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib. 장준, 정민규, 조병철, 홍수정, 강영애, 김대준, 김세규, 김세현, 김주항, 라선영, 이영주
2011 An indirect comparison of bevacizumab plus cisplatin-gemcitabine and cisplatin plus pemetrexed treatment for patients with advanced first-line non-squamous non-small cell lung cancer in East Asia. 김주항
2011 Cost-effectiveness of bevacizumab-based therapy versus cisplatin plus pemetrexed for the first-line treatment of advanced non-squamous NSCLC in Korea and Taiwan 김주항
2011 Comparative effectiveness of bevacizumab plus cisplatin-based chemotherapy versus pemetrexed plus cisplatin treatment in East Asian non-squamous non-small cell lung cancer patients applying real-life outcomes 김주항
2011 A randomized phase 3 trial comparing pemetrexed/carboplatin and docetaxel/carboplatin as first-line treatment for advanced, nonsquamous non-small cell lung cancer 김주항
2010 The role of monoclonal antibody in combination with first-line chemotherapy in Asian patients with advanced non-small cell lung cancer 김주항, 조병철
2010 Impact of environmental tobacco smoke on the incidence of mutations in epidermal growth factor receptor gene in never-smoker patients with non-small-cell lung cancer. 김세규, 김주항, 문진욱, 박인규, 이영주, 장준, 정경영, 조병철, 지선하
2010 Weekly 5-fluorouracil plus cisplatin for concurrent chemoradiotherapy in patients with locally advanced head and neck cancer 이영주, 이창걸, 조병철, 최은창, 최혜진, 김귀언, 김주항, 손주혁
2010 Frequent central nervous system failure after clinical benefit with epidermal growth factor receptor tyrosine kinase inhibitors in Korean patients with nonsmall-cell lung cancer. 김세규, 김주항, 문진욱, 박인규, 이영주, 장준, 조병철, 최혜진
2010 Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL 김주항, 김호근, 윤채옥, 이민걸, 장송남, 최경주, 최일규
2010 Acquired resistance to cetuximab is mediated by increased PTEN instability and leads cross-resistance to gefitinib in HCC827 NSCLC cells. 김선미, 김주항, 김지수, 김현기, 윤채옥, 조병철, 최수영
2010 Paclitaxel combined with ifosfamide in anthracycline- and docetaxel-pretreated metastatic breast cancer: activity independence of prior docetaxel resistance 구자승, 김승일, 김주항, 노재경, 문용화, 박병우, 박세호, 손주혁, 장현, 정현철, 최혜진
2010 Belotecan for relapsing small-cell lung cancer patients initially treated with an irinotecan-containing chemotherapy: a phase II trial 김세규, 김세현, 김주항, 박무석, 손주혁, 신상준, 장준, 정민규, 정재헌, 조병철, 최혜진
2010 Randomized Phase III trial of gefitinib versus docetaxel in non-small cell lung cancer patients who have previously received platinum-based chemotherapy 김주항
2010 Dose effect of cigarette smoking on frequency and spectrum of epidermal growth factor receptor gene mutations in Korean patients with non-small cell lung cancer. 김주항, 김현기, 김호근, 심효섭, 조병철, 홍수정, 강영애, 김세규
2010 Prognostic factors in small cell lung cancer: a new prognostic index in Korean patients 김세규, 김주항, 박경수, 이수현, 정민규, 조병철, 최혜진, 홍수정
2009 Phase II study of transarterial holmium-166-chitosan complex treatment in patients with a single, large hepatocellular carcinoma 유내춘, 이종두, 이종태, 최혜진, 김주항, 박경수, 손주혁
2009 Activating mutations within the EGFR kinase domain: a molecular predictor of disease-free survival in resected pulmonary adenocarcinoma. 김세규, 김주항, 김호근, 문진욱, 박무석, 박인규, 장준, 정경영, 조병철, 최혜진
2009 High tumor metabolic activity as measured by fluorodeoxyglucose positron emission tomography is associated with poor prognosis in limited and extensive stage small-cell lung cancer. 문진욱, 박인규, 윤미진, 장준, 조병철, 최혜진, 김세규, 김주항
2009 Double E1B 19 kDa- and E1B 55 kDa-deleted oncolytic adenovirus in combination with radiotherapy elicits an enhanced anti-tumor effect 김주항, 김평환, 성진실, 윤채옥, 최혜진
2009 Weekly docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck 금기창, 김세헌, 김주항, 신상준, 조병철, 최은창, 최혜진
2009 비소세포성 폐암으로 수술 후 방사선치료가 시행된 N2병기 환자들에서 다발 부위 종격동 림프절 전이 여부에 따른 N2병기 구분의 임상적 의미 김주항, 이익재, 이진구, 이창걸, 정경영, 조병철, 김용배
2009 Adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided versus empirical chemotherapy in unresectable non-small cell lung cancer 문용화, 손주혁, 이영주, 장준, 장현, 정민규, 정재헌, 홍수정, 김세규, 김주항
2009 Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study 김주항
2009 Brain metastases from hepatocellular carcinoma: prognostic factors and outcome: brain metastasis from HCC 김세현, 김주항, 손주혁, 신상준, 유내춘, 조병철, 최혜진
2009 Complete response of recurrent squamous cell carcinoma of the lung: dose the dose matter? 김주항, 김현기, 신상훈, 이영주, 조병철, 최혜진
2008 Chemoradiotherapy with or without consolidation chemotherapy using cisplatin and 5-fluorouracil in anal squamous cell carcinoma: long-term results in 31 patients 노재경, 성진실, 손주혁, 안중배, 정현철, 조병철, 김남규, 김주항
2008 A single institutional experience of surgically resected thymic epithelial tumors over 10 years: clinical outcomes and clinicopathologic features 손주혁, 유내춘, 이창걸, 장준, 정경영, 조병철, 최혜진, 김대준, 김범경, 김세규, 김주항, 박무석
2008 Combination of topotecan and etoposide as a salvage treatment for patients with recurrent small cell lung cancer following irinotecan and platinum first-line chemotherapy. 조병철, 최혜진, 김세규, 김주항, 손주혁, 신상준, 장준, 전성하, 정종열
2008 Novel cancer antiangiotherapy using the VEGF promoter-targeted artificial zinc-finger protein and oncolytic adenovirus 유지영, 윤채옥, 강윤아, 김주항
2008 Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition 강윤아, 김재성, 김주항, 윤채옥
2008 The number of residual metastatic lymph nodes following neoadjuvant chemotherapy predicts survival in patients with stage III NSCLC. 박무석, 손주혁, 신상준, 장준, 김대준, 정경영, 김세규, 조병철, 김세현, 최혜진, 김주항
2007 Hybrid nanoparticles for magnetic resonance imaging of target-specific viral gene delivery 김주항, 김평환, 서진석, 윤채옥, 이은숙, 허용민
2007 Identical epidermal growth factor receptor mutations in adenocarcinomatous and squamous cell carcinomatous components of adenosquamous carcinoma of the lung 강신명, 강현주, 김성규, 김세규, 김주항, 김호근, 신동환, 장준, 정경영
2007 Adenosine Tiphosphate-based Chemotherapy Response Assay (ATP-CRA)-guided platinum-based 2-drug chemotherapy for unresectable nonsmall-cell lung cancer 문용화, 박무석, 손주혁, 정경영, 김세규, 김용태, 김주항
2007 Phase II trial of irinotecan and cisplatin with early concurrent radiotherapy in limited-disease small-cell lung cancer 문용화, 손주혁, 이창걸, 장준, 정경영, 최병욱, 최혜진, 김귀언, 김세규, 김영삼, 김주항
2007 Treatment outcomes of 70 cases of early esophageal carcinoma: 12 years of experience 김주항, 김충배, 박승우, 송시영, 윤영훈, 이용찬, 정재복
2007 E1A- and E1B-double mutant replicating adenovirus elicits enhanced oncolytic and antitumor effects 김재성, 김주항, 김평환, 윤채옥, 최경주
2007 Clinical significance of cyclooxygenase-2 expression in extranodal natural killer (NK)/T-cell lymphoma, nasal type 금웅섭, 김귀언, 김용배, 김주항, 서창옥, 심수정, 양우익, 조재호
2007 Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib 신상준, 임종근, 장준, 조병철, 최혜진, 김세규, 김유진, 김주항, 김호근, 박무석, 박종필, 손주혁
2007 Retargeting of adenoviral gene delivery via Herceptin-PEG-adenovirus conjugates to breast cancer cells 김주항, 손주혁, 양재문, 윤채옥, 허용민
2007 VEGF-specific short hairpin RNA-expressing oncolytic adenovirus elicits potent inhibition of angiogenesis and tumor growth 김남규, 김주항, 유지영, 윤채옥, 최혜진
2007 Multi-disciplinary treatment of a rare pelvic cavity ependymoma 손주혁, 한승진, 황혜진, 김주항, 김태승
2006 Comparison of stage-specific outcome of breast cancer based on 5th and 6th AJCC staging system 김귀언, 김승일, 김주항, 박병우, 양우익, 이경식
2006 The changes of estrogen receptor-β variants expression in breast carcinogenesis: Decrease of estrogen receptor-β2 expression is the key event in breast cancer development 김귀언, 김승일, 김주항, 박병우, 양우익
2006 Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect 손주혁, 윤채옥, 김귀언, 김주항, 김호근
2006 Markedly Enhanced Cytolysis by E1B-19kD-Deleted Oncolytic Adenovirus in Combination with Cisplatin 김주항, 김호근, 박병우, 손주혁, 윤채옥
2006 Enhanced Antitumor Effect of Oncolytic Adenovirus Expressing Interleukin-12 and B7-1 in an Immunocompetent Murine Model 김주항, 김호근, 윤채옥
2006 Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy 김주항, 김호근, 윤채옥
2006 Paclitaxel and leucovorin-modulated infusional 5-fluorouracil combination chemotherapy for metastatic gastric cancer 김주항, 김충배, 손주혁, 안중배, 이용찬
2006 A phase II trial of fractionated irinotecan plus carboplatin for previously untreated extensive-disease small cell lung cancer 이창걸, 장준, 김대준, 김세규, 김주항, 손주혁, 정경영
2006 Generation of a rabbit VH domain antibody polyspecific to c-Met and adenoviral knob protein 김주항, 윤채옥
2005 A Pilot Study of Trans-Arterial Injection of 166Holmium-Chitosan Complex for Treatment of Small Hepatocellular Carcinoma 김주항, 노재경, 손주혁, 안중배, 유내춘, 이종두, 이종태, 정현철, 조병철, 최혜진
2005 Correlation of KIT and platelet-derived growth factor receptor α mutations with gene activation and expression profiles in gastrointestinal stromal tumors 강현주, 이환석, 형우진, 김주항, 김현기, 김혜령, 노성훈, 윤채옥, 김호근
2005 Enhanced Oncolytic Effect and Anti-Tumor Effect of Replication Competent Adenovirus with Double Mutation in E1A & E1B Regions 김재성, 김주항, 김평환, 손주혁, 윤채옥, 최경주
2005 Coxsackie and adenovirus receptor binding ablation reduces adenovirus liver tropism and toxicity 김귀언, 김민정, 김주항, 김호근, 유지영, 윤아름, 윤채옥
2005 ADP-overexpressing adenovirus elicits enhanced cytopathic effect by induction of apoptosis 구태영, 김호근, 윤채옥, 이영숙, 김은희, 김주항
2004 Lack of Correlation Between P-glycoprotein and Chemotherapy Resistance in Nasal NK/T-cell Lymphomas 김귀언, 김주항, 노재경, 라선영, 서창옥, 양우익, 유내춘, 이상욱, 정현철, 조재호, 한지숙
2004 Clinical relevance of three subtypes of primary sinonasal lymphoma characterized by immunophenotypic analysis 금기창, 금웅섭, 김귀언, 김주항, 노재경, 서창옥, 양우익, 이상욱, 이창걸, 한지숙
2004 Prognosis of thymic epithelial tumors according to the new World Health Organization histologic classification 김세규, 김주항, 박무석, 양우익
2004 악성 흉막액에서 CEA와 CYFRA 21-1의 진단적 유용성 김세규, 김영삼, 김주항, 문진욱, 박무석, 장준, 정재호, 황상연, 김성규
2003 Clinical features of bronchogenic large cell carcinoma confirmed by surgical resection. 정경영, 정재호, 정재희, 김도훈, 김성규, 김세규, 김영삼, 김주항, 박무석, 신동환, 장준
2003 Optimization of vesicular stomatitis virus-G pseudotyped feline immunodeficiency virus vector for minimized cytotoxicity with efficient gene transfer 송재진, 장진우, 김주항
2003 dl-VSVG-LacZ, a VSV-G epitope incorporated adenoviurs exhibit marked enhancement in gene transduction efficiency 김주항, 손주혁, 송재진, 윤채옥
2003 Increased Cytopathic Effect of Replicating Adenovirus Expressing Adenovirus Death Protein 김주항, 손주혁, 윤채옥
2003 A Case of Paraneoplastic Nephrotic Syndrome in a Patient with Ovarian Carcinoma 라선영, 손주혁, 심지영, 유내춘, 정현철, 한대석, 김용태, 김주항, 김철, 노재경
2003 Ad-mTERT-Δ19, a Conditional Replication-Competent Adenovirus Driven by the Human Telomerase Promoter, Selectively Replicates in and Elicits Cytopathic Effect in a Cancer Cell-Specific Manner 김주항, 김호근, 손주혁, 윤채옥
2002 폐암에 의한 악성 흉막삼출환자에서 OK-432와 Doxycycline 흉막유착술의 비교 곽승민, 김성규, 김세규, 김영삼, 김주항, 박무석, 장준, 정재호, 정재희
2002 Evaluation of E1b gene-attenuated replicating adenoviruses for cancer gene therapy 김주항, 윤채옥, 조재용
2002 Identification of MARCKS, FLJ11383 and TAF1B as putative novel target genes in colorectal carcinomas with mocrosatellite instability 김주항, 김호근, 이진성
2002 Antitumoral effects of recombinant adenovirus YKL-1001, conditionally replicating in α-fetoprotine-producing human liver cancer cells 김주항, 윤채옥
2001 CD5와 Cytokeratin 7에 음성이고 Cytokeratin 13에 양성인 흉선 편평상피세포암 1예 신동환, 장준, 정경영, 정재호, 김성규, 김세규, 김영삼, 김주항, 노태웅, 박무석, 손주혁
2001 Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck 김귀언, 김주항
2001 Evaluation of E1B - mutant Replicating Adenoviruses for Cancer Gene Therapy 김주항, 윤채옥
2001 Efficient gene transfer of VSV-G pseudotyped retroviral vector to human brain tumor 김주항, 송재진, 윤채옥, 장진우

Browse